ALPCO’s Post

We are going to be at #BPI2024 with the #CELLHANDLER in person. If you are attending the show, go hands-on at our booth 1442. The future of #CellLineDevelopment is Cellhandler. #BioProcessingInternational #AdenoAssociatedVirus #AAV #MicrobiomeBasedTherapeutics #Yamaha #LifeScience #AccellerateYourLab #SteamlineYourLab

🌍 Exciting News on World NTD Day! 🌍   Thrilled to announce that VenomAid Diagnostics has secured an extension of our seed round bringing it to a total of $1.8M for developing rapid snakebite diagnostics! 🐍🚀   Since the early days at DTU Bioengineering in 2018, our vision has been to reduce the global burden of snakebites, and today, on World NTD Day, we celebrate this milestone bringing us our vision one step closer to reality. This funding, which is quite a feat, is equivalent to 10% (!!!) of the global R&D funding awarded to snakebite in 2022) and will propel us toward clinical pilots in Brazil and scale up of manufacturing of our rapid tests. Snakebite envenoming claims over 100,000 lives annually and leaves many more with permanent sequelae, suffering from the socioeconomic consequences. Today, we're one step closer to transforming snakebite management with our affordable, easy-to-use diagnostic test.   Special thanks to our incredibly dedicated team: Cecilie Knudsen, Gina Ross, Pelle Degnegaard Knudsen, Selma Blom Belfakir, and Andreas Laustsen-Kiel, our fantastic board: Gert Fisker Tomczyk, Mads Laustsen, and Morten Munk, and our amazing investors for their relentless support and willingness to continue to FIGHT THE BITE.   ➡ Press release in the comments   #VenomAid #SnakebiteDiagnostics #GlobalHealth #Innovation #MedTech

📍 Are you heading to #ECTRIMS2024? Emma Gray from the MS Society is looking to speak to potential industry collaborators for the OCTOPUS clinical trial in progressive #MultipleScleroisis. Get in touch with Emma to find out more 👇 #MSResearch #Pharmaceuticals

#DIESSE #ESR team confirms his support for applied reaserch in diagnostic with five posters exibited at #SIBioC congress (Bologna 2024, October 8-10) showing the high performance of VES-MATIC 5, CUBE 30 touch, MINI-CUBE and meantime the ESR sensitivity and specificity

Yesterday at TechTalk XL in the beautiful NecstGen facility in Leiden. Nice picture of the Dutch ATMP industry landscape. Great to see that the majority of these companies are customer of Progress - Experts in Life Sciences. Many thanks to the event team of Leiden Bio Science Park for organising this event with great speakers and very interesting presentations about developments in the ATMP field. Amongst others about new indications (e.g. CAR-T's moving to solid cancers) and developments in QC release assays, amongst others a rapid sterility assay. Since time needed for QC release has/will become the time limiting factor, faster release assays are highly needed in the ATMP field. #ATMP #WeAccelerateImprovement

Tip of the day: For business leaders and decision makers in times of changes. If you already have not; Read or listen to the book: "Thinking, Fast and Slow". Written by Nobel Prize winner Psychologist Daniel Kahneman revolutionised our understanding of human behaviour The impact of loss aversion and overconfidence on corporate strategies, the difficulties of predicting what will make us happy in the future, the challenges of properly framing risks at work and at home, the profound effect of cognitive biases on everything from playing the stock market to planning the next vacation—each of these can be understood only by knowing how the two systems work together to shape our judgments and decisions. A promise: "Thinking, Fast and Slow" will transform the way you think about thinking. We are always inspired how managers can become better decisions makers, and we understand managers need of cost efficient and quick solutions of getting the current market perspectives in a rapid changing world. We have tested, developed and launched services that meet this need from our clients called Opticom Agile. Why decision-makers and business leaders should consider international market research an invaluable investment, particularly during times of uncertainty? Read below customer experience and get inspired. https://lnkd.in/d4JThAid

🔬 Exciting Update on #BSMO24! Brigitte Maes shares insights into the groundbreaking #BALLETT study, powered by @mybsmo and employing TSO500 for comprehensive genomic profiling. All results from TSO interpreted by our #oncokdm software. 🧬 Key Highlights: 🔍 Actionable Variants: Detected in an impressive 83% of patients, underlining the study's precision in identifying relevant genomic information. 💡 Treatment Recommendations: Remarkably, 70% of patients received tailored treatment recommendations based on genomic profiling. ⏭️ Follow-up Success: Encouragingly, 21% of patients have already initiated the recommended treatments, emphasizing the study's impact on patient care and outcomes. 🤔 Question: When will this kind of tumor profiling be reimbursed in Belgium? The urgency for widespread access to such innovative and personalized approaches to treatment is undeniable. Kudos to the dedicated team behind #BSMO24 for advancing precision medicine and paving the way for personalized treatment strategies! 🚀🌐 #GenomicProfiling #PrecisionMedicine #HealthcareInnovation #MedicalResearch

Check it out and visualize high throughput flow cytometry in action. #automation #cytometry #target #marker #immunotherapy #immuno #vaccin #CAR #phenotyping #screening #tumor #leukemia #lymphoma #immunooncology #autoummunity #drugdevelopment

SCOPE starts this weekend, and Segmed is thrilled to be a sponsor. Are you planning to attend this conference? Don't miss out on our latest blog article highlighting the Top Reasons You Can't Afford to Miss Segmed at the summit. Check it out https://hubs.li/Q02kbM3r0 #SCOPESummit #Segmed #ClinicalTrials #ClinicalResearch #ClinicalOperations #RWiD #ImagingDatasets

Join Scout at #OCTEU Did you know that replacing a patient on a clinical trial can cost around $20,000 on average? Stop by for a chat and discover how Scout's services can enhance patient engagement and help minimize the need for patient replacement. #patientcentric #welovewhatwedo #clinicaltrials